Arcturus Therapeutics Holdings Inc (ARCT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.32
• Market Cap: $235.84M
• EPS: $-2.46
• 52-Week High: $24.17
• 52-Week Low: $5.85

Market Sentiment

Arcturus Therapeutics Holdings Inc currently has a Neutral sentiment score of 0.12.

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc. is a pioneering biopharmaceutical company based in San Diego, California, dedicated to the development of RNA-based therapeutics aimed at addressing critical unmet medical needs, particularly in liver and respiratory diseases. The company leverages its proprietary RNA delivery platform to advance a promising pipeline of innovative drug candidates, focusing on enhancing patient outcomes. With a strong emphasis on technological advancements and industry exper...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Arcturus Therapeutics Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ARCT pay dividends?

Arcturus Therapeutics Holdings Inc (ARCT) does not currently pay a regular dividend.

What is ARCT's market cap?

Arcturus Therapeutics Holdings Inc (ARCT) has a market capitalization of $235.84M with a current stock price of $8.32.